FORWARD FEATURES CALENDAR

Launches & Fundraising

NovaQuest Capital closes USD275m in dedicated private equity fund

NovaQuest Capital Management, a healthcare and life sciences focused private investment firm, has held the final close of NovaQuest Private Equity Fund I (Fund I) with USD275 million in total capital commitments. Fund I will continue NovaQuest’s focus on investing in and building leading services and technologies in the healthcare and

Aruwa Capital Management launches USD20m co-investment vehicle for Africa

Aruwa Capital Management (Aruwa), a female founded and led private equity firm focussed on Nigeria and Ghana, has launched a USD20 million co-investment vehicle. Aruwa‘s mission is to provide patient growth capital to established and rapidly growing companies in the small to lower middle market and it expects to execute

Clocktower closes second financial services innovation VC fund

Clocktower Technology Ventures (CTV), the venture capital investment arm of Clocktower Group, a client-focused alternative investment firm employing opportunistic strategies across public and private markets, has held the final close of the firm’s second financial services innovation fund, Clocktower Technologies II (CTV2). Focused exclusively on investments in early stage fintech

HIG Capital closes USD3.1bn HIG Middle Market LBO Fund III above target

Global alternative asset management firm HIG Capital (HIG) has closed the HIG Middle Market LBO Fund III with aggregate capital commitments of USD3.1 billion, well exceeding its target. The Fund will continue the strategy of HIG Middle Market’s two predecessor funds, by making private equity investments in middle market companies,

Wellington Management closes Biomedical Innovation Fund I at USD393m

Independent management and investment firm, Wellington Management (Wellington), has announced the final close of the Wellington Biomedical Innovation Fund I (the Fund).  At the point of closure, the Fund was oversubscribed.   The Fund will invest in private biotechnology companies focused on drug discovery and development, and seeking capital to advance

Mirova’s Althelia Sustainable Ocean Fund raises additional USD50m

Mirova Natural Capital wholly owned by sustainable investment manager Mirova, an affiliate of Natixis Investment Managers, has held the second close of the Althelia Sustainable Ocean Fund (SOF), a fund dedicated to making pioneering impact investments into marine and coastal projects and enterprises that can deliver sustainable economic returns in

Albion Capital holds first close of Real Assets Fund

Albion Capital, an independent investment manager, has held the first close of its new asset-backed private equity fund, Albion Real Assets Fund (ARAF). First close investors include the GBP9 billion Merseyside Pension Fund and several high net worth families. ARAF is a continuation of Albion Capital’s successful asset-backed investment strategy

MMC Ventures launches GBP100m Scale Up Fund

MMC Ventures, a research-led VC investor, has launched a new GBP100 million Scale Up Fund to provide expansion capital to its later-stage portfolio companies.  The Scale Up Fund will provide primary capital to current portfolio companies that have grown beyond the mandate of MMC Ventures’ existing funds. The Scale Up

British Patient Capital commits USD45m to Balderton Fund VII

British Patient Capital, a subsidiary of the British Business Bank, has committed USD45 million to Balderton Capital Fund VII, as it closes at USD400 million. The fund will focus on the Series A stage to support outstanding founders at this critical point in a start-up’s journey.   As with previous

Events

12 November, 2026 – 5:00 pm

Directory Listings